Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qualyst Transporter Solutions
Durham, North Carolina, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Qualyst Transporter Solutions commercialized proprietary in vitro hepatic models and assays, most notably using the B-CLEAR technology, to advance prediction of drug-induced liver effects and drug transport in preclinical research settings. It did not develop therapeutic products but set standards for hepatocyte function in research and built proprietary technologies widely used for in vitro liver research[4][6].
- Therapeutic areas
- GastroenterologyOtherMetabolic Disorders
- Industry
- Drug Discovery Services
Beyond the preview
Go deeper on Qualyst Transporter Solutions.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qualyst Transporter Solutions.